FI901876A0 - OFULLSTAENDIGA HEPADNAVIRUS, VACCIN PRODUCERANDE CELLINJER SAMT THERAPY AV LEVERSJUKDOMAR. - Google Patents

OFULLSTAENDIGA HEPADNAVIRUS, VACCIN PRODUCERANDE CELLINJER SAMT THERAPY AV LEVERSJUKDOMAR.

Info

Publication number
FI901876A0
FI901876A0 FI901876A FI901876A FI901876A0 FI 901876 A0 FI901876 A0 FI 901876A0 FI 901876 A FI901876 A FI 901876A FI 901876 A FI901876 A FI 901876A FI 901876 A0 FI901876 A0 FI 901876A0
Authority
FI
Finland
Prior art keywords
producerande
ofullstaendiga
leversjukdomar
cellinjer
vaccin
Prior art date
Application number
FI901876A
Other languages
Finnish (fi)
Inventor
Arthur Louis Horwich
Jesse William Summers
Original Assignee
Univ Yale
Fox Chase Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale, Fox Chase Cancer Center filed Critical Univ Yale
Publication of FI901876A0 publication Critical patent/FI901876A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI901876A 1988-08-16 1990-04-12 OFULLSTAENDIGA HEPADNAVIRUS, VACCIN PRODUCERANDE CELLINJER SAMT THERAPY AV LEVERSJUKDOMAR. FI901876A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23281188A 1988-08-16 1988-08-16
PCT/US1989/003521 WO1990002176A1 (en) 1988-08-16 1989-08-16 Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders

Publications (1)

Publication Number Publication Date
FI901876A0 true FI901876A0 (en) 1990-04-12

Family

ID=22874695

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901876A FI901876A0 (en) 1988-08-16 1990-04-12 OFULLSTAENDIGA HEPADNAVIRUS, VACCIN PRODUCERANDE CELLINJER SAMT THERAPY AV LEVERSJUKDOMAR.

Country Status (8)

Country Link
EP (1) EP0380656A1 (en)
AU (1) AU4315689A (en)
DK (1) DK93390A (en)
FI (1) FI901876A0 (en)
IE (1) IE892640L (en)
IL (1) IL91335A0 (en)
WO (1) WO1990002176A1 (en)
ZA (1) ZA896246B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081022A1 (en) * 1990-04-20 1991-10-21 Hubert E. Blum Methods of preventing viral replication
US5610050A (en) * 1990-04-20 1997-03-11 The General Hospital Corporation Methods of preventing viral replication
FR2716459B1 (en) * 1994-02-22 1996-05-10 Univ Paris Curie Host-vector system usable in gene therapy.
US5869248A (en) * 1994-03-07 1999-02-09 Yale University Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
US6057153A (en) * 1995-01-13 2000-05-02 Yale University Stabilized external guide sequences
US5683873A (en) * 1995-01-13 1997-11-04 Innovir Laboratories, Inc. EGS-mediated inactivation of target RNA
DE19517532C2 (en) 1995-05-12 1999-10-28 Max Planck Gesellschaft HBV vectors and cells for their delivery
WO1998011916A1 (en) * 1996-09-18 1998-03-26 The Board Of Regents Of The University Of Texas System Viral defective interfering particles and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861588A (en) * 1985-02-05 1989-08-29 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers

Also Published As

Publication number Publication date
IE892640L (en) 1990-02-16
DK93390A (en) 1990-06-15
ZA896246B (en) 1990-06-27
AU4315689A (en) 1990-03-23
DK93390D0 (en) 1990-04-11
IL91335A0 (en) 1990-03-19
EP0380656A1 (en) 1990-08-08
WO1990002176A1 (en) 1990-03-08

Similar Documents

Publication Publication Date Title
ATE101608T1 (en) THERAPEUTIC CHINUCLIDE DERIVATIVES.
ATE120194T1 (en) THERAPEUTIC NULEOSIDES.
NO894270L (en) SYNERGISTIC SWEATER, AND PROCEDURE FOR THE PREPARATION OF SUCH A.
DE68922559D1 (en) Clock-sensitive two-chamber pacemaker.
FI894688A0 (en) FLYTANDE ORALT TAGBART THERAPEUTIC SYSTEM.
FI890488A0 (en) VAEXTEXTRAKT INNEHAOLLANDE PHARMACEUTICAL PREPARATION SAMT FOERFARANDE FOER FRAMSTAELLNING DAERAV.
DE68907177D1 (en) DOSAGE FORM.
FI884048A (en) FOERFARANDE FOER BESTAEMNING AV HALTEN AV EN GASKOMPONENT I EN PATIENTS ANDNINGSLUFT.
FI893596A0 (en) AV TVENNE DELAR FRAMSTAELLD, MED PLAN LOCKYTA OMFATTANDE BEHAOLLARE.
FI893897A (en) THERAPEUTIC NUCLEOSIDER.
FI901876A0 (en) OFULLSTAENDIGA HEPADNAVIRUS, VACCIN PRODUCERANDE CELLINJER SAMT THERAPY AV LEVERSJUKDOMAR.
FI905236A0 (en) DEOXIRIBONUCLEOSIDER INNEHAOLLANDE PHARMACEUTICAL CONSISTENT FOER LAEKNING AV SAOR.
FI894321A0 (en) THERAPEUTIC AEMNEN.
FI894072A (en) POLYPEPTIDER ANVAENDBARA SOM VACCIN.
DE68924645D1 (en) ADMINISTRATION MACHINE.
FI87013B (en) BRAENNINGSFOERFARANDE FOER MINSKANDE AV BILDNING AV KVAEVEOXIDER I SAMBAND MED FOERBRAENNING SAMT ANORDNING FOER TILLAEMPANDE AV FOERFARANDET.
FI892118A0 (en) ENSKIKTIGT NAOLSOEMTYG MED LODRAETA SOEMNINGSLAENKAR, SAMT FOERFARANDE.
NO904235D0 (en) IMPROVED CYTOTOXIC THERAPY.
NO901574D0 (en) THERAPEUTIC AGENTS.
NO901573L (en) THERAPEUTIC AGENTS.
FI880169A0 (en) MASSAGEANORDNING FOER MASSAGE AV EN RYGG.
NO912254L (en) THERAPEUTIC DECAPEPTIDES.
FI881199A0 (en) EXPRESSION AV PROTEINER I VAEXTER.
FI885006A0 (en) FOERFARANDE FOER BEHANDLING AV OSTKORN I EN OSTFORM ANORDNAD I EN OSTPANNA SAMT EN OSTFORM-, OSTPANNA- KOMBINATION FOER TILLAEMPNING AV FOERFARANDET.
FI881475A0 (en) FOERFARANDE FOER STYRNING AV EN HISSKORG I LEDSKENOR SAMT EN FOER TILLAEMPNING AV FOERFARANDET AVSEDD HISSKORGENHET.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: FOX CHASE CANCER CENTER

Owner name: YALE UNIVERSITY